• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Retatrutide 2381089-83-2
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution

Biocon receives 12 USFDA observations for Malaysia unit

biospectrumasiaJuly 10, 2019

Tag:

Indian biopharmaceutical company Biocon has announced that its Sdn Bhd’s Insulin Glargine Drug Substance, Drug Product and Device assembly facilities in Malaysia underwent a pre-approval inspection by the U.S. FDA between June 24 and July 5, 2019. The inspection across these 3 units concluded with 12 observations issued on the Form 483.

The company will respond to the FDA with a Corrective and Preventive Action Plan and are confident of addressing these observations expeditiously. Biocon does not expect any change to its commercialization plans for Insulin glargine in the U.S. Biocon remains committed to global standards of Quality and Compliance.

Previous:NUS opens new centre for oral health

Next:DTC genetic testing market size to exceed $2.5bn by 2025

Related News

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

PRNewswireDecember 18, 2024

Seoul 120 hotline has contributed to efficient city operation, according to the Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) released on Wednesday.

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 h

PRNewswireDecember 18, 2024

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

PRNewswireDecember 18, 2024

Biocon receives 12 USFDA observations for Malaysia unit | Pharmasources.com

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PRNewswireDecember 19, 2024

Pharus Diagnostics LLC. (PharusDx), announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight

You may like
More>>

N-o-methylphenyl-(N-hydroxy) methyl carbamate

N-o-methylphenyl-(N-hydroxy) methyl carbamate
Fish Collagen

Fish Collagen
3-Fluoro-4-Morpholin-4-yl-Phenylamine

3-Fluoro-4-Morpholin-4-yl-Phenylamine
L-Theanine

L-Theanine
FMOC-L-2-Methylphe

FMOC-L-2-Methylphe
Carbimazole

Carbimazole
Jujube Seed Extract Jujuboside

Jujube Seed Extract Jujuboside
INFUSION BOTTLE FILLING LINE

INFUSION BOTTLE FILLING LINE
6-bromo-2-dibenzofuranol

6-bromo-2-dibenzofuranol
Ectoine

Ectoine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service